Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancer
- 1 March 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (3) , 413-416
- https://doi.org/10.1016/0959-8049(95)00517-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapyBreast Cancer Research and Treatment, 1994
- A current view of tamoxifen for the treatment and prevention of breast cancerBritish Journal of Pharmacology, 1993
- The future of new pure antiestrogens in clinical breast cancerBreast Cancer Research and Treatment, 1993
- Drug resistance to tamoxifen during breast cancer therapyBreast Cancer Research and Treatment, 1993
- Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines.Journal of Biological Chemistry, 1992
- Acquired Tamoxifen Resistance: Correlation With Reduced Breast Tumor Levels of Tamoxifen and Isomerization of Trans-4-HydroxytamoxifenJNCI Journal of the National Cancer Institute, 1991
- The Mechanism of ICI 164,384 Antiestrogenieity Involves Rapid Loss of Estrogen Receptor in Uterine TissueEndocrinology, 1991
- Modulation of estrogen receptor and epidermal growth factor receptor mRNAs by phorbol ester in MCF 7 breast cancer cellsBiochemical and Biophysical Research Communications, 1989
- Growth regulatory peptide production by human breast carcinoma cellsJournal of Steroid Biochemistry, 1988
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988